EcoDrugPlus

Carbonic Anhydrase 7

Ensembl ID : ENSCVAG00000015284
Gene Symbol: CA7
3 Cross references
222 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSCVAG00000013509
Gene Symbol: CA4C
1 Cross references
201 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSCVAG00000010206
Gene Symbol: CSNK1E
3 Cross references
199 Possible Orthologues:

Casein Kinase I Isoform Epsilon-Like

Ensembl ID : ENSCVAG00000023326
Gene Symbol: LOC107089544
3 Cross references
205 Possible Orthologues:

Caspase 9

Ensembl ID : ENSCVAG00000012532
Gene Symbol: CASP9
3 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSCVAG00000001175
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSCVAG00000018043
Gene Symbol: CTSC
3 Cross references
239 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSCVAG00000019029
Gene Symbol: LOC107086845
3 Cross references
226 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSCVAG00000019022
Gene Symbol: LOC107086772
3 Cross references
235 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSCVAG00000000173
Gene Symbol: LOC107088360
2 Cross references
181 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSCVAG00000004980
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4a

Ensembl ID : ENSCVAG00000005654
Gene Symbol: CXCR4A
1 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).